Sotac Pharmaceuticals (NSE:SOTAC) General and Admin. Expense: ₹0.0 Mil (TTM As of Sep. 2025)


NSE:SOTAC Sotac Pharmaceuticals Ltd NSE:SOTAC
55 GF Score
Price ₹101.00
GF Value ₹110.01
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Sotac Pharmaceuticals General and Admin. Expense?

Sotac Pharmaceuticals NSE:SOTAC 55 General and Admin. Expense is ₹0.0 Mil as of Sep. 2025. GuruFocus rates NSE:SOTAC with a GF Score™ of 55/100 and a GF Value™ of ₹110.01 (Fairly Valued). The stock has 6 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Sotac Pharmaceuticals's General and Admin. Expense for the six months ended in Sep. 2025 was ₹0.0 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2025 was ₹0.0 Mil.

Sotac Pharmaceuticals General and Admin. Expense Related Terms

Sotac Pharmaceuticals General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Sotac Pharmaceuticals's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sotac Pharmaceuticals General and Admin. Expense Chart

Sotac Pharmaceuticals Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
General and Admin. Expense
Get a 7-Day Free Trial 2.59 2.34 8.40 5.56 6.80

Sotac Pharmaceuticals Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:SOTAC
55GF Score
Sotac Pharmaceuticals Ltd NSE:SOTAC
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sotac Pharmaceuticals General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of ₹0.0 Mil mean?
Sotac Pharmaceuticals (NSE:SOTAC) has a General and Admin. Expense of ₹0.0 Mil as of Sep. 2025. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Sotac Pharmaceuticals and its competitors.
Is Sotac Pharmaceuticals' General and Admin. Expense too high?
Sotac Pharmaceuticals' current General and Admin. Expense is ₹0.0 Mil. Overall, Sotac Pharmaceuticals has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sotac Pharmaceuticals' General and Admin. Expense compare to ZTS and UTHR?
Sotac Pharmaceuticals' General and Admin. Expense of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Drug Manufacturers company?
A good General and Admin. Expense depends on the Drug Manufacturers industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Sotac Pharmaceuticals and its competitors. Sotac Pharmaceuticals's current General and Admin. Expense is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sotac Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Sotac Pharmaceuticals (NSE:SOTAC) is currently considered Fairly Valued. The stock's GF Value™ is ₹110.01, compared to a current price of ₹101.00 — trading 8.2% below its estimated fair value. The current General and Admin. Expense is ₹0.0 Mil. Sotac Pharmaceuticals' overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Sotac Pharmaceuticals (NSE:SOTAC), the current General and Admin. Expense is ₹0.0 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sotac Pharmaceuticals (NSE:SOTAC) Overvalued in 2026?

Based on GuruFocus' analysis, Sotac Pharmaceuticals stock appears to be undervalued. The current stock price of ₹101.00 is trading 8.2% below its estimated GF Value™ of ₹110.01. GuruFocus considers Sotac Pharmaceuticals to be Fairly Valued.

Key valuation signals for NSE:SOTAC:

  • General and Admin. Expense: ₹0.0 Mil
  • GF Value™: ₹110.01 vs. price of ₹101.00 (8.2% below fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the NSE:SOTAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sotac Pharmaceuticals Business Description

Address Plot No. PF-21 & PF-22/A, Charal Industrial Estate, Sanand GIDC-II, Sanand, Ahmedabad, GJ, IND, 382110
Sotac Pharmaceuticals Ltd operates chiefly in pharmaceutical manufacturing, serving a broad range of therapeutic segments including anti-diabetic, anti-psychotic, vitamins and minerals, anti-cold, anti-allergic, derma products, antacids, anti-ulcerants, cardiac, analgesic, anti-bacterial, anti-fungal, and more. The company manufactures tablets, capsules, syrups, and external preparations under contract manufacturing and loan licensing agreements, for domestic and international markets. Its clients include notable pharmaceutical marketers such as Cadila Pharma and Viatris. Revenue is distributed between domestic pharmaceutical product sales and international exports, supporting scalable growth across geographies.
55GF Score

Get the complete analysis for NSE:SOTAC

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹101.00
Price
₹110.01
GF Value